Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 30 December 2025

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

NEW YORK, December 30, 2025, 13:14 ET — Regular session Corcept Therapeutics Inc shares fell 8.9% to $72.72 in early afternoon Nasdaq trading on Tuesday, after touching a session low of $72.26. The stock was last down $7.10 from Monday’s close, with about 897,000 shares traded. The decline comes as investors focus on Corcept on the day the U.S. Food and Drug Administration is due to decide on relacorilant, its experimental treatment for endogenous hypercortisolism, also known as Cushing’s syndrome. Under the Prescription Drug User Fee Act, or PDUFA, the FDA sets a target date for taking action on a
30 December 2025
··
Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today

Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today

NEW YORK, December 30, 2025, 13:01 ET — Regular session Equinox Gold Corp shares rose about 2.2% on Tuesday, trading around $14.30, as a rebound in gold prices lifted the sector. The stock traded between $14.18 and $14.58, with about 2.2 million shares changing hands. The move matters because the gold market has turned choppy into year-end after a powerful run, and miners often magnify bullion swings. A small change in the gold price can quickly reshape expectations for miners’ cash flow. Investors are also positioning around the Federal Reserve’s December meeting minutes, due later Tuesday, for clues on how
30 December 2025
··
Target stock slips today as activist pressure stays in focus — what investors are watching next

Target stock slips today as activist pressure stays in focus — what investors are watching next

NEW YORK, December 30, 2025, 12:56 ET — Regular session Target Corp shares were down 0.7% at $97.38 in midday trading on Tuesday, lagging a modest dip across retail names. The stock’s move comes as investors keep focus on activist scrutiny of the big-box retailer, a fresh overhang after a report that hedge fund Toms Capital Investment Management has built a significant, but undisclosed, position. The Star Why it matters now: Target is trying to halt a sales slide and reset expectations with a leadership handover looming, after the company posted three straight quarters of declining comparable sales — a
30 December 2025
·
IREN stock slips today as year-end tech jitters hit AI data-center plays

IREN stock slips today as year-end tech jitters hit AI data-center plays

NEW YORK, December 30, 2025, 12:56 ET — Regular session Shares of IREN Ltd fell 1.4% to $38.87 in midday trading on Tuesday, pulling back after an early climb to $39.94. The slide matters because IREN has become a high-beta proxy for two crowded trades at once: bitcoin-linked miners and AI data-center buildouts. That mix can amplify moves when liquidity thins late in the year and investors rotate out of riskier growth names. Reuters It also keeps attention on capital needs. IREN is building out AI infrastructure, and traders have stayed sensitive to any hint of equity dilution or added
30 December 2025
GE Aerospace stock is up today as GE shares steady after ex-dividend reset

GE Aerospace stock is up today as GE shares steady after ex-dividend reset

NEW YORK, December 30, 2025, 13:05 ET — Regular session GE Aerospace shares edged higher on Tuesday, up about 0.2% at $312.2 in afternoon trading in New York. The move comes in holiday-thin markets, when light liquidity can make small shifts in positioning look bigger than they are. For GE, the calendar matters: the stock began trading ex-dividend on Monday, meaning new buyers no longer qualify for the next quarterly payout. GE fell 1% on Monday and finished about 2% below its 52-week high of $318.06 set last week, while peers Honeywell and RTX slipped less, MarketWatch data showed. MarketWatch
30 December 2025
·····
AbbVie stock slips today as Fed minutes loom in thin year-end trade

AbbVie stock slips today as Fed minutes loom in thin year-end trade

NEW YORK, December 30, 2025, 12:55 ET — Regular session AbbVie Inc. shares fell 0.8% to $228.89 in midday trading on Tuesday. The stock ranged between $228.66 and $231.55 after opening at $230.77, with volume near 795,000 shares. The move came as Wall Street traded with little direction in holiday-thinned turnover, leaving the Dow down 0.24%, the S&P 500 off 0.09% and the Nasdaq lower by 0.07% around midday, Reuters reported. Investors were awaiting minutes from the Federal Reserve’s Dec. 9-10 meeting, when it cut rates by 25 basis points — a quarter of a percentage point — but signaled
30 December 2025
···
T-Mobile stock is up today: TMUS holds steady as Fed minutes loom in thin year-end trade

T-Mobile stock is up today: TMUS holds steady as Fed minutes loom in thin year-end trade

NEW YORK, December 30, 2025, 12:45 ET — Regular session Shares of T-Mobile US, Inc. (TMUS) were up about 0.2% at $203.55 in midday trade on Tuesday. The stock has traded between $202.00 and $203.71 so far in the session. The modest move came as U.S. stocks hovered near flat in a holiday-truncated week, with communication services among the day’s stronger pockets and investors awaiting minutes from the Federal Reserve’s Dec. 9-10 meeting later in the day. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide, referring
30 December 2025
·
Why Newmont stock is up today: gold rebounds and Fed minutes loom

Why Newmont stock is up today: gold rebounds and Fed minutes loom

NEW YORK, December 30, 2025, 13:00 ET — Regular session Newmont Corp shares rose 2.7% to $102.48 by 12:44 p.m. ET on Tuesday, after trading between $100.31 and $102.70. Volume stood at about 3.36 million shares. The move mattered because it followed a sharp reversal in precious metals and mining stocks on Monday, when Newmont was the worst-performing stock in the S&P 500, down nearly 6%. CME’s higher margin requirements — the cash traders must post to hold futures positions — added to the pressure across metals-linked trades. Investopedia Gold’s direction remains the main macro driver for the sector at
30 December 2025
···
Pan American Silver stock today: PAAS climbs as silver rebounds after margin shakeout

Pan American Silver stock today: PAAS climbs as silver rebounds after margin shakeout

NEW YORK, December 30, 2025, 12:49 ET — Regular session Pan American Silver Corp (PAAS) shares rose 2.1% to $53.36 by 12:49 p.m. ET on Tuesday, tracking a rebound across silver-linked miners. The stock traded between $52.44 and $54.32, with about 2.6 million shares changing hands. The move matters because silver has been whipsawed into the final days of the year, and miners often magnify those swings. For producers, revenue moves with the metal while many operating costs remain relatively fixed in the short run. That operating leverage can boost cash flow quickly when silver rises, but it can also
30 December 2025
··
Crocs stock today: CROX snaps back after a 6% drop as Fed minutes loom

Crocs stock today: CROX snaps back after a 6% drop as Fed minutes loom

NEW YORK, December 30, 2025, 12:45 ET — Regular session Crocs Inc shares rose 0.6% to $86.49 in midday trading on Tuesday, stabilizing after Monday’s sharp decline. The stock fell 6.2% in the prior session and sits about 30% below its 52-week high. investing.com The move matters because late-December liquidity can amplify swings, especially in consumer-facing names that sit at the intersection of rates and spending. Crocs has been caught in that crosscurrent after a volatile stretch into year-end. Investors are trying to separate short-term tape action from the bigger question: whether Crocs can keep demand steady while protecting margins
30 December 2025
··
Gold Fields stock rebounds as gold steadies, with Fed minutes next

Gold Fields stock rebounds as gold steadies, with Fed minutes next

NEW YORK, December 30, 2025, 12:43 ET — Regular session Gold Fields Limited shares rose about 2.5% to $44.69 in midday trading on Tuesday, recovering some ground after the prior session’s selloff. The U.S.-listed ADR traded between $44.07 and $45.47. The bounce matters because gold-linked assets have been swinging sharply into year-end, a period when thin liquidity can exaggerate price moves. Gold and silver slid hard on Monday after the CME raised margin requirements — the cash traders must post to hold futures positions — prompting profit-taking. Investopedia Investors also have a fresh catalyst later on Tuesday: minutes from the
30 December 2025
···
Johnson & Johnson stock today: JNJ slips after $3.05B Halda cancer deal closes, Barclays lifts target

Johnson & Johnson stock today: JNJ slips after $3.05B Halda cancer deal closes, Barclays lifts target

NEW YORK, December 30, 2025, 12:44 ET — Regular session Johnson & Johnson shares edged lower on Tuesday after the company said it completed its $3.05 billion cash purchase of cancer-therapy developer Halda Therapeutics. The stock was down about 0.2% at $207.12 in midday trading. Executive vice president Jennifer Taubert called the closing a “strategic milestone” as J&J flagged about $0.20 of dilution to adjusted earnings per share — profit per share excluding certain one-time items — split between 2025 and 2026. Johnson & Johnson Investor Relations The closing gives J&J a new platform aimed at developing oral, targeted cancer
30 December 2025
··
Reddit stock price today barely moves as CTO share-sale filing and AI-search thesis collide

Reddit stock price today barely moves as CTO share-sale filing and AI-search thesis collide

NEW YORK, December 30, 2025, 12:33 ET — Regular session Reddit shares were little changed on Tuesday, holding near $234.60 in midday trading, as investors digested an insider sale disclosed in a regulatory filing and a fresh round of bullish talk on the company’s role in AI-driven search. The muted move matters because Reddit has been one of the market’s standout winners since its March 2024 debut, and attention is shifting from momentum to whether the platform can keep turning AI-driven attention into ad dollars. A year-end tape that has been broadly calm leaves company-specific signals — even routine ones
30 December 2025
··
IAMGOLD (IAG) stock rises as gold rebounds from margin-driven selloff; Fed minutes ahead

IAMGOLD (IAG) stock rises as gold rebounds from margin-driven selloff; Fed minutes ahead

NEW YORK, December 30, 2025, 12:44 ET — Regular session Shares of IAMGOLD Corporation (NYSE: IAG) rose about 2.3% to $16.86 by 12:44 p.m. ET on Tuesday, tracking a rebound in bullion after a sharp pullback a day earlier. The stock was up from Monday’s close of $16.48 and traded between $16.48 and $16.99. The move matters because gold miners have been whipsawed into year-end, with prices reacting quickly to shifts in precious metals and investor positioning. In Canada, mining shares helped push the TSX higher on Tuesday as gold and silver recovered, while investors waited for fresh signals from
30 December 2025
···
Linde stock edges higher in thin year-end trade as investors eye Fed minutes

Linde stock edges higher in thin year-end trade as investors eye Fed minutes

NEW YORK, December 30, 2025, 12:34 ET — Regular session Linde plc shares edged higher on Tuesday as investors navigated thin year-end trading and awaited fresh signals on U.S. interest rates. The industrial gases company’s stock was up 0.2% at $427.21 by midday, while the SPDR S&P 500 ETF was down 0.1%. The small move matters now because late-December trading can exaggerate price swings. Investors are also watching for central bank clues that could move bond yields and, by extension, valuations across industrial and materials-linked names. “I wouldn’t try to make too much out of anything that happens in a
30 December 2025
··
Agnico Eagle stock rebounds today as gold steadies; Fed minutes in focus

Agnico Eagle stock rebounds today as gold steadies; Fed minutes in focus

NEW YORK, December 30, 2025, 12:38 ET — Regular session Agnico Eagle Mines Ltd (AEM) rose about 1.2% to around $173.5 in midday trading on Tuesday, recouping part of the prior session’s drop as gold prices rebounded. The Canadian gold producer closed Monday at $171.34, down 6.48% from Friday, and is up about 121% so far this year. MarketScreener The move matters because gold miners are trading like a levered bet on bullion in the final days of 2025, after a record run-up and an abrupt pullback. With liquidity thinning into year-end, small shifts in rates and positioning are translating
30 December 2025
···
Newmont stock rises as gold rebounds; Raymond James lifts $111 target

Newmont stock rises as gold rebounds; Raymond James lifts $111 target

NEW YORK, December 30, 2025, 12:32 ET — Regular session Newmont Corp shares rose about 2.2% to $102.00 in midday trading on Tuesday. The gain puts the world’s largest listed gold miner back in sync with bullion after an abrupt bout of profit-taking jolted metals markets this week. The timing matters because investors are repositioning into year-end, and gold has become a crowded macro trade tied to rate expectations and geopolitical risk. Newmont fell 5.6% on Monday as precious metals sold off sharply, leaving the stock primed to swing with any bounce in gold. Barron’s Spot gold rose 0.9% to
30 December 2025
··
Adobe stock barely budges near $353 as Fed minutes loom — what ADBE investors watch next

Adobe stock barely budges near $353 as Fed minutes loom — what ADBE investors watch next

NEW YORK, December 30, 2025, 12:26 ET — Regular session Adobe shares were little changed on Tuesday, trading near $353 as investors braced for the Federal Reserve’s latest policy meeting minutes later in the day. The “minutes” — the detailed record of the Fed’s meeting — matter now because rate expectations can swing Treasury yields and, in turn, valuations for long-duration growth stocks such as software companies. Minutes from the Fed’s Dec. 9-10 meeting are due at 2 p.m. ET, after policymakers cut rates by a quarter point (0.25 percentage point) to a 3.50%-3.75% range, a decision that drew three
30 December 2025
··
Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX

Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX

NEW YORK, December 30, 2025, 12:33 ET — Regular session Edgewise Therapeutics shares were up 0.2% at $24.68 as of 12:18 p.m. ET on Tuesday, after a Form 144 filing showed company officer Robert Michael Carruthers sold 116,665 shares worth about $3.04 million on Dec. 26. The stock traded between $24.40 and $24.92. SEC The disclosure matters because Edgewise is a development-stage biotech, where trading often centers on clinical milestones and cash runway rather than product sales. Insider transactions can draw outsized attention after sharp moves, even when the dollar amounts are modest. Biotech stocks also lagged, with the iShares
30 December 2025
·
AST SpaceMobile stock jumps 6% today as launch cadence and insider buy lift sentiment

AST SpaceMobile stock jumps 6% today as launch cadence and insider buy lift sentiment

NEW YORK, December 30, 2025, 12:19 ET — Regular session Shares of AST SpaceMobile (ASTS) rose 6.5% to $76.09 in midday trading on Tuesday, after the satellite-to-smartphone firm and one of its carrier partners flagged progress toward a larger constellation. The stock opened at $72.10 and traded between $72.07 and $78.27, with about 10.6 million shares changing hands. The rally matters because AST is trying to prove it can deliver “direct-to-device” service — a satellite link that works with standard smartphones without special hardware — and investors are using each launch and testing milestone as a readout on execution. Reuters
30 December 2025
··
1 … 557 558 559 560 561 … 1,170

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
New York, Feb 7, 2026, 11:29 ET — Market closed. AbbVie shares closed up 2% on Friday at $223.43, extending a second straight session of gains as U.S. stocks rallied. The stock is still roughly 9% below its 52-week high, and trading volume ran a bit under its recent average. (MarketWatch) The bounce comes as investors work through AbbVie’s post-earnings reset and what it means for 2026. The drugmaker said fourth-quarter net revenues rose 10% to $16.618 billion and adjusted profit per share—excluding certain items—was $2.71; it forecast 2026 adjusted earnings of $14.37 to $14.57 a share. Chief Executive Robert
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop